Insider Sale: CFO Julia Wang Sells Shares of BeiGene Ltd (BGNE)_老虎社区_美港股上老虎

Insider Sale: CFO Julia Wang Sells Shares of BeiGene Ltd (BGNE)

GuruFocus.com06-27

On June 24, 2024, Julia Wang, Chief Financial Officer of BeiGene Ltd (NASDAQ:BGNE), executed a sale of 899 shares of the company at a price of $155.66 per share. This transaction was documented in an ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

期权初学者
·06-27
43万股，卖了899股？
回复
1
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2446045763?lang=zh_CN&edition=full","thumbnail":"https://s.yimg.com/uu/api/res/1.2/A5yWnhjFMQnizvYMAewIqQ--~B/aD01NDM7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/1f69525dc61949209532ca716c99a9e7","is_english":true,"pubTime":"2024-06-27 15:16","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2446045763","market":"us","top_or_hot":-1,"title":"Insider Sale: CFO Julia Wang Sells Shares of BeiGene Ltd (BGNE)","media":"GuruFocus.com","content":"<div>\n<p>On June 24, 2024, Julia Wang, Chief Financial Officer of BeiGene Ltd (NASDAQ:BGNE), executed a sale of 899 shares of the company at a price of $155.66 per share. This transaction was documented in an ...</p>\n\n<a href=\"https://finance.yahoo.com/news/insider-sale-cfo-julia-wang-071622751.html\">网页链接</a>\n\n</div>\n","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Insider Sale: CFO Julia Wang Sells Shares of BeiGene Ltd (BGNE)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInsider Sale: CFO Julia Wang Sells Shares of BeiGene Ltd (BGNE)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-27 15:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/insider-sale-cfo-julia-wang-071622751.html><strong>GuruFocus.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>On June 24, 2024, Julia Wang, Chief Financial Officer of BeiGene Ltd (NASDAQ:BGNE), executed a sale of 899 shares of the company at a price of $155.66 per share. This transaction was documented in an ...</p>\n\n<a href=\"https://finance.yahoo.com/news/insider-sale-cfo-julia-wang-071622751.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4585","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"https://finance.yahoo.com/news/insider-sale-cfo-julia-wang-071622751.html","article_id":"2446045763","we_media_id":null,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/A5yWnhjFMQnizvYMAewIqQ--~B/aD01NDM7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/1f69525dc61949209532ca716c99a9e7"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2446045763","pubTimestamp":1719472582,"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"On June 24, 2024, Julia Wang, Chief Financial Officer of BeiGene Ltd , executed a sale of 899 shares of the company at a price of $155.66 per share. This transaction was documented in an SEC Filing. Following this sale, the insider now owns 432,731 shares of BeiGene Ltd.GuruFocus has detected 5 Warning Signs with BGNE.BeiGene Ltd  is a global biotechnology company focused on developing molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company aims to provide access to innovative, affordable medicines in order to improve treatment outcomes and access for patients worldwide.Over the past year, Julia Wang has sold a total of 2,684 shares and has not purchased any shares. The insider transaction history for BeiGene Ltd shows a total of 15 insider sells and no insider buys over the past year.This insider sale may be of interest to investors tracking insider behaviors and the valuation metrics of BeiGene Ltd.","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4585":"ETF&股票定投概念","BK4505":"高瓴资本持仓","BK4139":"生物科技","BK4504":"桥水持仓","BK4588":"碎股","BK4526":"热门中概股","BGNE":"百济神州","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓"},"translate_title":"内幕出售：首席财务官Julia Wang出售百济神州有限公司(BGNE)股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BGNE":1},"content_text":"On June 24, 2024, Julia Wang, Chief Financial Officer of BeiGene Ltd (NASDAQ:BGNE), executed a sale of 899 shares of the company at a price of $155.66 per share. This transaction was documented in an SEC Filing. Following this sale, the insider now owns 432,731 shares of BeiGene Ltd.\n\nWarning! GuruFocus has detected 5 Warning Signs with BGNE.\n\nBeiGene Ltd (NASDAQ:BGNE) is a global biotechnology company focused on developing molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company aims to provide access to innovative, affordable medicines in order to improve treatment outcomes and access for patients worldwide.\nOver the past year, Julia Wang has sold a total of 2,684 shares and has not purchased any shares. The insider transaction history for BeiGene Ltd shows a total of 15 insider sells and no insider buys over the past year.\nShares of BeiGene Ltd were trading at $155.66 on the day of the sale, giving the company a market cap of $16.497 billion. According to the GF Value, the stock has a price-to-GF-Value ratio of 0.35, indicating that it is a Possible Value Trap, Think Twice.\nThe GF Value is calculated based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on the companys past returns and growth, and future estimates of business performance from Morningstar analysts.\n\n\nThis insider sale may be of interest to investors tracking insider behaviors and the valuation metrics of BeiGene Ltd.\nThis article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.This article first appeared on \nGuruFocus.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":321389045178488,"gmtCreate":1719495439341,"gmtModify":1719495441440,"author":{"id":"4091928867421130","authorId":"4091928867421130","name":"期权初学者","avatar":"https://static.tigerbbs.com/d42a60d4553a11531362e3a43714f8d7","vip":1,"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":5,"crmLevelSwitch":1},"htmlText":"43万股，卖了899股？","listText":"43万股，卖了899股？","text":"43万股，卖了899股？","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/321389045178488","repostId":2446045763,"repostType":2,"repost":{"id":"2446045763","pubTimestamp":1719472582,"share":"https://www.laohu8.com/m/news/2446045763?lang=&edition=full","pubTime":"2024-06-27 15:16","market":"us","language":"en","title":"Insider Sale: CFO Julia Wang Sells Shares of BeiGene Ltd (BGNE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2446045763","media":"GuruFocus.com","summary":"On June 24, 2024, Julia Wang, Chief Financial Officer of BeiGene Ltd , executed a sale of 899 shares of the company at a price of $155.66 per share. This transaction was documented in an SEC Filing. Following this sale, the insider now owns 432,731 shares of BeiGene Ltd.GuruFocus has detected 5 Warning Signs with BGNE.BeiGene Ltd  is a global biotechnology company focused on developing molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company aims to provide access to innovative, affordable medicines in order to improve treatment outcomes and access for patients worldwide.Over the past year, Julia Wang has sold a total of 2,684 shares and has not purchased any shares. The insider transaction history for BeiGene Ltd shows a total of 15 insider sells and no insider buys over the past year.This insider sale may be of interest to investors tracking insider behaviors and the valuation metrics of BeiGene Ltd.","content":"<html><body><p>On June 24, 2024, Julia Wang, Chief Financial Officer of BeiGene Ltd (NASDAQ:BGNE), executed a sale of 899 shares of the company at a price of $155.66 per share. This transaction was documented in an SEC Filing. Following this sale, the insider now owns 432,731 shares of BeiGene Ltd.</p>\n<ul>\n<li>Warning! GuruFocus has detected 5 Warning Signs with BGNE.</li>\n</ul>\n<p>BeiGene Ltd (NASDAQ:BGNE) is a global biotechnology company focused on developing molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company aims to provide access to innovative, affordable medicines in order to improve treatment outcomes and access for patients worldwide.</p>\n<p>Over the past year, Julia Wang has sold a total of 2,684 shares and has not purchased any shares. The insider transaction history for BeiGene Ltd shows a total of 15 insider sells and no insider buys over the past year.</p>\n<p>Shares of BeiGene Ltd were trading at $155.66 on the day of the sale, giving the company a market cap of $16.497 billion. According to the GF Value, the stock has a price-to-GF-Value ratio of 0.35, indicating that it is a Possible Value Trap, Think Twice.</p>\n<p>The GF Value is calculated based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on the companys past returns and growth, and future estimates of business performance from Morningstar analysts.</p>\n<p><img height=\"400\" src=\"https://s.yimg.com/uu/api/res/1.2/X0FkRheRI5Scv_bH9VENsA--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/us.finance.gurufocus/1f69525dc61949209532ca716c99a9e7\" width=\"550\"/></p>\n<p><img height=\"400\" src=\"https://s1.yimg.com/uu/api/res/1.2/JnHhI4H0Q3w9JGyjJL5w3A--/cT03NTthcHBpZD15dmlkZW9mZWVkczs-/https://media.zenfs.com/en/us.finance.gurufocus/e0ce154977f0cf6fdea6ade8e91ff919\" width=\"550\"/></p>\n<p>This insider sale may be of interest to investors tracking insider behaviors and the valuation metrics of BeiGene Ltd.</p>\n<p><em>This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.</em></p>This article first appeared on \nGuruFocus.\n<br/></body></html>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Insider Sale: CFO Julia Wang Sells Shares of BeiGene Ltd (BGNE)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInsider Sale: CFO Julia Wang Sells Shares of BeiGene Ltd (BGNE)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-27 15:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/insider-sale-cfo-julia-wang-071622751.html><strong>GuruFocus.com</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>On June 24, 2024, Julia Wang, Chief Financial Officer of BeiGene Ltd (NASDAQ:BGNE), executed a sale of 899 shares of the company at a price of $155.66 per share. This transaction was documented in an ...</p>\n\n<a href=\"https://finance.yahoo.com/news/insider-sale-cfo-julia-wang-071622751.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://s.yimg.com/uu/api/res/1.2/A5yWnhjFMQnizvYMAewIqQ--~B/aD01NDM7dz0xMjQyO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/us.finance.gurufocus/1f69525dc61949209532ca716c99a9e7","relate_stocks":{"BK4585":"ETF&股票定投概念","BK4505":"高瓴资本持仓","BK4139":"生物科技","BK4504":"桥水持仓","BK4588":"碎股","BK4526":"热门中概股","BGNE":"百济神州","BK4535":"淡马锡持仓","BK4548":"巴美列捷福持仓"},"source_url":"https://finance.yahoo.com/news/insider-sale-cfo-julia-wang-071622751.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2446045763","content_text":"On June 24, 2024, Julia Wang, Chief Financial Officer of BeiGene Ltd (NASDAQ:BGNE), executed a sale of 899 shares of the company at a price of $155.66 per share. This transaction was documented in an SEC Filing. Following this sale, the insider now owns 432,731 shares of BeiGene Ltd.\n\nWarning! GuruFocus has detected 5 Warning Signs with BGNE.\n\nBeiGene Ltd (NASDAQ:BGNE) is a global biotechnology company focused on developing molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company aims to provide access to innovative, affordable medicines in order to improve treatment outcomes and access for patients worldwide.\nOver the past year, Julia Wang has sold a total of 2,684 shares and has not purchased any shares. The insider transaction history for BeiGene Ltd shows a total of 15 insider sells and no insider buys over the past year.\nShares of BeiGene Ltd were trading at $155.66 on the day of the sale, giving the company a market cap of $16.497 billion. According to the GF Value, the stock has a price-to-GF-Value ratio of 0.35, indicating that it is a Possible Value Trap, Think Twice.\nThe GF Value is calculated based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on the companys past returns and growth, and future estimates of business performance from Morningstar analysts.\n\n\nThis insider sale may be of interest to investors tracking insider behaviors and the valuation metrics of BeiGene Ltd.\nThis article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.This article first appeared on \nGuruFocus.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":0,"commentSize":1,"repostSize":2,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}